BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$74.13
+4.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 20.77x
- P/S forward
- 10.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.76x
- Price / sales
- 20.32x
- Price / cash flow
- -33.36x
Enterprise value
- Enterprise value
- $16.3B
- EV / sales
- 22.82x
- EV / EBITDA
- -26.62x
- EV / EBIT
- -29.95x
- Market cap
- $14.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026